Congenital Obstructive Nephropathy: Clinical Perspectives and Animal Models by Susan E. Ingraham & Kirk M. McHugh
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1 
Congenital Obstructive Nephropathy: 
 Clinical Perspectives and Animal Models 
Susan E. Ingraham and Kirk M. McHugh 
Department of Pediatrics, Division of Pediatric Nephrology, The Ohio State University 
and The Research Institute at Nationwide Children’s Hospital, 
Columbus, Ohio, 
 USA 
1. Introduction  
Congenital obstructive nephropathy is the leading cause of pediatric chronic kidney disease 
(CKD). Consequently, it engenders a tremendous societal burden in terms of morbidity and 
mortality and in health care expenses over the lifespan of affected patients. The challenges 
clinicians face in the diagnosis, prognosis, and treatment of congenital obstructive 
nephropathy illustrate the utility of developing effective experimental models for the study 
of this complex disease process. In this review, we characterize congenital obstructive 
nephropathy with its myriad causes and manifestations, outline current standards of 
diagnosis and care, and discuss experimental animal models with relevance in unraveling 
clinical conundrums and molecular mechanisms of this important renal disease. 
Congenital obstructive nephropathy is a complex process of pathologic changes in kidney 
development and function that arise when antegrade urine flow is impaired beginning in 
utero. The term congenital obstructive uropathy is frequently used to describe this condition. 
However, every urologic obstruction – whether anatomic, mechanical, or functional – 
should be approached with the knowledge that obstruction can affect the kidneys. For this 
reason, we prefer the term congenital obstructive nephropathy. 
Intrinsic anatomic obstructions may occur in isolation or accompanied by other pathology 
such as renal hypodysplasia. Functional obstructions also occur, which may be transient and 
self-resolving, or chronic with potentially profound consequences on renal function. 
Although the etiologies of congenital obstructive nephropathy are myriad, any restriction of 
urine flow has the potential to produce hydronephrosis, altered renal development, and 
progression of CKD. This direct link between obstructed urine flow and abnormal kidneys 
represents a central paradigm of urogenital pathogenesis that has far-reaching implications 
(Woolf & Thiruchelvam, 2001). 
2. Epidemiology of congenital obstructive nephropathy 
Congenital obstructive nephropathy is the most common cause of CKD in children and is 
among the top three etiologies of pediatric end-stage renal disease (ESRD; NAPRTCS, 2009). 
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Congenital obstructive nephropathy is often grouped with renal agenesis, 
hypoplasia/dysplasia and other abnormalities as a heterogeneous entity termed congenital 
anomalies of the kidney and urinary tract (CAKUT). CAKUT is relatively common, affecting up 
to 2% of pregnancies (Ismaili et al., 2003; Wiesel et al., 2005). CAKUT accounts for 51% of 
childhood CKD in North America (NAPRTCS, 2009), and similar frequencies in registry 
data from around the world (Neild, 2009a). Among the diagnoses within the broad category 
of CAKUT, obstructive disease carries the greatest risk for developing ESRD (Sanna-Cherchi 
et al., 2009). The association of renal hypodysplasia and impaired glomerular filtration rate 
with urological obstruction is well-established. More subtle renal changes such as 
hypertension, impaired sodium/water handling, and acidosis are also common (Farnham et 
al., 2005; Gillenwater et al., 1975). Thus the full clinical impact of congenital obstructive 
nephropathy is immense. 
3. Classification of congenital obstructive nephropathy 
The timing, extent, etiology, and location of impaired urine flow are important 
considerations in describing and classifying the causes of obstructive nephropathy. One of 
the most important and useful distinctions is the anatomic level at which the obstruction 
occurs – namely, the upper urinary tract (kidney or ureter) versus the lower urinary tract 
(bladder, bladder outlet or urethra). Upper urinary tract lesions have little potential to 
affect the contralateral kidney, whereas lower tract anomalies generally put both kidneys 
at risk.  
3.1 Upper urinary tract obstructions 
Congenital obstructions of the upper urinary tract include ureteropelvic junction (UPJ) and 
ureterovesical junction (UVJ) obstructions, as well as obstructing ureteroceles and other 
anomalies of ureteric structure or position.  
3.1.1 Ureteropelvic junction obstruction 
UPJ obstruction is the most common congenital urological obstruction (Figure 1). It occurs in 
one of every 1000-2000 births, with a 3:1 male predominance. Obstruction is bilateral in 20-
25% of cases (Woodward & Frank, 2002). Congenital UPJ obstructions usually arise from an 
adynamic proximal ureteral segment. This dysfunctional segment of the ureter often 
exhibits abnormal distribution of collagen and/or smooth muscle, and may show altered 
innervation or vasculature (Hosgor et al., 2005; Payabvash et al., 2007; Yoon et al., 1998). 
Less common intrinsic causes of UPJ obstruction include a convoluted ureteral course and 
deformations of the mucosa, including valve-like folds or polyps. UPJ obstruction may also 
arise from extrinsic compression of the proximal ureter by another structure such as 
aberrant vasculature or fibrous bands.  
3.1.2 Ureterovesical junction obstruction 
UVJ obstruction, or primary obstructive megaureter, arises when urine flow is restricted at 
or near the insertion of the ureter into the bladder (Figure 2). This is the second most 
common site of congenital obstruction, after the UPJ (Brown et al., 1987; Reinberg et al., 
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1991). UVJ  obstruction is four times more common in males and arises more often on the 
left, with bilateral obstructions occurring in up to 25% of cases (Gimpel et al., 2010; 
Woodward & Frank, 2002). Like UPJ obstruction, UVJ obstruction is typically associated 
with an adynamic ureteric segment that fails to propagate effective urine flow. 
 
Fig. 1. Radiological findings associated with UPJ obstruction in an 18 month old female. Left 
hydronephrosis was detected prenatally, and the patient had normal postnatal renal 
function with no vesicoureteral reflux (VUR). She was managed conservatively, with 
gradual improvement in hydronephrosis on serial imaging studies through age 15 months. 
However, at 18 months of age hydronephrosis worsened. A - C. Ultrasound of urinary 
bladder (A), right (B) and left (C) kidneys. The bladder (A) is normal in conformation with 
normal wall thickness, and no hydroureter is seen. The right kidney (B) is structurally 
normal with slight pelviectasis. The left kidney (C) demonstrates marked hydronephrosis 
with blunted calyces and thinned parenchyma, which had worsened from previous findings 
of moderate but improving hydronephrosis. D and E. Technetium-99m MAG3 diuretic renal 
scan using the F+20 protocol confirmed a left ureteropelvic junction obstruction. Sequential 
posterior images of the abdomen and pelvis (D) are grouped into perfusion, parenchymal, 
and excretion phases. Ten milligrams of furosemide were administered 20 minutes after 
tracer injection. With injection of the tracer, there is bolus visualization of the inferior vena 
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cava, followed by prompt visualization of renal parenchyma bilaterally. On the right side, 
there is prompt cortical transit and accumulation in a normal-caliber collecting system 
followed by appropriate washout. Renogram curve (E) shows a normal right drainage half-
time (T1/2) of 8.9 minutes. On the left side, the kidney is enlarged with central photopenia 
consistent with hydronephrosis. Cortical transit is slightly delayed on the left compared to 
the right. In the excretion phase, tracer accumulates in the hydronephrotic collecting system 
but there is no washout of the radiopharmaceutical from the left kidney. Left T1/2 was not 
reached in the duration of the study. The patient subsequently underwent left pyeloplasty 
for UPJ obstruction. 
 
Fig. 2. Radiological findings associated with UVJ obstruction in a 4 month old male. A - C. 
Ultrasound of urinary bladder (A), right (B) and left (C) kidneys. The bladder (BL) is normal 
in conformation with a smooth wall of normal thickness. Bilateral distal hydroureter is seen, 
greater on the right (RU) than the left (LU). The right kidney (B) is moderately 
hydronephrotic with well-preserved parenchyma. The left kidney (C) demonstrates normal 
echotexture and no hydronephrosis, but urothelial thickening is seen. D - F. Technetium-
99m MAG3 diuretic renal scan using the F+20 protocol confirmed a right UVJ obstruction. 
Sequential posterior images are shown for the excretion phase only (D). Renogram curves 
are illustrated for both kidneys (E) as well as for both ureters (F). Appropriate excretion is 
observed in the left kidney and ureter both before and after administration of furosemide. 
On the right side, minimal excretion is demonstrated prior to and following the diuretic. 
Renal T1/2 is 2.3 minutes on the left and never reached on the right.  
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3.1.3 Ureterocele 
Ureteroceles are cystic dilations of the submucosal or intravesical segment of a ureter 
(Figure 3). If the opening to the ureterocele is stenotic or ectopically positioned, 
obstruction often results. The prevalence of ureterocele is 1 in 5000 newborns. Unlike the 
majority of obstructive lesions, ureteroceles demonstrate a female predominance 
(Woodward & Frank, 2002). Ureteroceles are often associated with a duplex collecting 
system and/or ectopic ureteral insertion. Depending on the location, configuration and 
size, unilateral ureteroceles may cause bilateral obstruction. Bilateral ureteroceles are 
present in 20-50% of cases (Pohl et al., 2007).  
 
 
 
Fig. 3. Radiological findings associated with ureterocele in a 6 day old male. A and B. 
Voiding cystourethrogram (VCUG). Filling image (A) shows the ureterocele as an ovoid 
filling defect (red arrow). Voiding image (B) shows eversion of the ureterocele (yellow 
arrow) through an ectopic ureteral insertion, resembling a congenital paraurethral 
diverticulum. C – E. Ultrasound of urinary bladder (C), right (D) and left (E) kidneys. The 
bladder (BL, image C) is minimally distended but demonstrates smooth walls of normal 
thickness. Within the bladder, the thin rounded septation (white arrowhead) delineating the 
ureterocele (UC) is seen. A markedly dilated right distal ureter (RU) is also evident on this 
lateral, longitudinal view. The right hydroureter is associated with right upper pole 
hydronephrosis (RUP, image D) in a duplex right kidney. There is minimal hydronephrosis 
in the right lower pole duplex moiety. A duplex kidney is also observed on the left (E), with 
no hydronephrosis.  
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3.1.4 Other upper urinary tract obstructions 
Although less common than UPJ or UVJ obstructions, congenital obstructions can arise 
elsewhere within the kidney or along the course of the ureter. Examples include 
infundibular or infundibulopelvic stenosis, which may be idiopathic or associated with 
Beckwith-Wiedemann or Bardet-Biedl syndrome; anomalous ureteric position, such as a 
retroiliac or retrocaval course; and mid-ureteral stricture. 
3.2 Lower urinary tract obstructions 
There are several congenital anomalies that result in chronic lower urinary tract obstruction, 
the most familiar being posterior urethral valves (PUV). Other inborn causes of lower 
urinary tract obstruction include urethral atresia, stenosis or hypoplasia; anterior urethral 
valves; urethral diverticula; and cloacal anomalies. Congenital lower urinary tract 
obstructions put both kidneys at risk for abnormalities in fetal renal development and 
impaired renal function, and may be associated with oligohydramnios and pulmonary 
hypoplasia. Congenital lower urinary tract obstructions may also result in bladder 
dysfunction, ultimately leading to a secondary functional obstruction that may require 
careful management to optimize renal outcomes.  
3.2.1 Posterior urethral valves  
PUV, also known as congenital obstructing posterior urethral membrane, is found in 1 out of 
5000-8000 live births, and occurs only in males (King, 1985). Oligohydramnios is a common 
consequence, and renal dysplasia may also be present. Using postnatal fluoroscopic VCUG, 
the gold standard for diagnosis of PUV and other lower urinary tract obstructions 
(Riedmiller et al., 2001), the classic finding for PUV is a linear filling defect in the column of 
radiocontrast filling a markedly dilated posterior urethra. However, this distinct linear 
radiolucent band corresponding to the “valve” is not always seen, because the obstructing 
membrane can become distended and take on a more sail-like or windsock appearance, as 
shown in Figure 4. Secondary VUR is found in 25-50% of PUV cases (Agarwal, 1999). In a 
subset of patients, unilateral VUR may provide a “pop-off” effect, whereby renal tissue and 
function on the non-refluxing side is preserved at the expense of severe dysplasia and 
dysfunction in the refluxing kidney (Greenfield et al., 1983). 
3.2.2 Urethral atresia, stenosis, or hypoplasia 
Although PUV is the most common cause of congenital lower urinary tract obstruction 
postnatally, detailed postmortem analysis of fetuses with megacystis and hyperechogenic 
kidneys showed that isolated severe lower urinary tract obstruction before 25 weeks’ 
gestation was as likely to be due to urethral atresia or stenosis as PUV (Robyr et al., 2005). 
Urethral atresia may arise in association with complex collections of other genitourinary 
and/or gastrointestinal anomalies. Moreover, urethral atresia may be a cause of bladder 
outlet obstruction in females whereas PUV is not. Urethral atresia is incompatible with life 
unless an alternative connection between the bladder and the amniotic sac is present. 
Prenatal surgical decompression has been performed to relieve this obstruction, although a 
spontaneous fistula or patent urachus may also provide the necessary bladder drainage  
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Fig. 4. Radiological findings associated with PUV in a 2 day old male. A - C. Ultrasound of 
urinary bladder (A), right (B) and left (C) kidneys. The bladder (BL) is rounded with a 
thickened and trabeculated wall. This patient had severe hydroureter bilaterally, although 
only the left ureter (LU) is clearly observed in image A. Moderate to severe hydronephrosis 
is present bilaterally, with thinning of the cortex, increased echogenicity relative to the liver 
(LIV), and poor corticomedullary differentiation. One fluid-filled area (CY) in the right 
kidney did not clearly communicate with the collecting system, and likely represents a large 
cyst. D and E. VCUG. The lobulated and undulating contours of the urinary bladder (BL) 
reflect thickening and trabeculation of the bladder wall. The posterior urethra (PU) is 
dilated. Rather than the classic abrupt transition to a normal caliber anterior urethra, this 
patient has the “wind-sock” appearance generated by distal prolapse or distention of the 
valve membrane (arrow). VUR into a tortuous and dilated left ureter (LU) is obvious. 
(Gonzalez et al., 2001; Herndon & Casale, 2002). An association between urethral atresia and 
prune belly syndrome has been recognized (Reinberg et al., 1993). Progression to ESRD is 
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common, although not universal, in surviving patients with urethral atresia (Gonzalez, et 
al., 2001).  
3.2.3 Prolapsing ureterocele 
Large ureteroceles can prolapse through the urethra, which may result in bladder outlet 
obstruction. This is most frequently an acquired condition, although rarely prolapse may 
occur in utero, leading to features of congenital obstructive nephropathy (Sozubir et al., 
2003).  
3.2.4 Other urethral obstructions 
Urethral diverticula and anterior urethral valves are rare causes of infravesicular 
obstruction. Interestingly, although bladder pathology and variable degrees of 
hydroureteronephrosis result, renal function is usually not impaired after surgical correction 
of the obstruction (Arena et al., 2009; Gupta & Srinivas, 2000; Rawat et al., 2009). 
3.3 Functional obstruction 
Functional urological obstructions are conditions that result in impaired antegrade urine 
flow without evidence of a physical blockage. In many patients, the situation may be 
transient and can ultimately resolve without intervention, in which case a specific etiology 
may never be identified. In other cases a functional obstruction may result from myogenic 
or neurogenic causes, which can result in lifelong voiding dysfunction as well as significant 
renal impairment. Examples include conditions such as congenital neurogenic bladder 
(Ewalt & Bauer, 1996), congenital non-neurogenic neurogenic bladder (Vidal et al., 2009), 
and prune belly syndrome (Woodhouse et al., 1982). 
3.4 Multisystem conditions associated with obstruction or voiding dysfunction 
3.4.1 Prune belly syndrome 
Prune belly syndrome (Figure 5), also known as Eagle-Barrett syndrome, consists of the 
triad of underdeveloped abdominal wall musculature, urinary tract dilatation, and 
undescended testicles (Eagle & Barrett, 1950). Postnatally, urinary obstruction in prune 
belly syndrome is often functional rather than anatomic in nature. Prune belly syndrome 
has an incidence of 3.8 per 100,000 male births (Routh et al., 2010). The condition also 
occurs rarely in females, albeit necessarily lacking cryptorchidism (Reinberg, et al., 1991). 
Secondary VUR is present in 85% of patients with prune belly syndrome, and associated 
anomalies of the gastrointestinal, pulmonary, skeletal, and/or cardiac systems are 
common (Strand, 2004). 
Two major theories, which are not mutually exclusive, have been advocated regarding the 
development of prune belly syndrome. One proposes that the condition arises from a 
fundamental flaw in mesoderm development (Straub & Spranger, 1981), while the other 
suggests that prune belly syndrome originates from a severe fetal urethral obstruction that 
results in massive distention of the bladder, degeneration of the abdominal wall 
musculature, and interruption of testicular descent (Pagon et al., 1979).  
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Fig. 5. Radiological findings associated with prune belly syndrome in a 2 day old male. 
A - E. Ultrasound of urinary bladder (A), right (B) and left (C) ureters, right (D) and left (E) 
kidneys. The bladder (BL) is decompressed but bladder wall thickness is normal. Tortuous 
dilated ureters (U, RU, LU) are observed bilaterally in the lower abdomen. The kidneys are 
dysplastic and amorphous in appearance, with cysts of varying sizes. There is no 
corticomedullary differentiation in either kidney. F. VCUG. The protuberant abdomen 
resulting from lack of abdominal wall musculature is evident from the position of bowel 
loops (arrows) on this lateral view. This patient has an unusual configuration of the bladder, 
bladder base and posterior urethra. There is absence of the normal prostate and a very 
distended posterior urethra (PU) connecting to a dysplastic-appearing bladder (BL). No 
evidence of true PUV was found on this or any subsequent investigations. Reflux is 
observed into the distended right ureter (RU) but not the left. G. VCUG from another 
patient 10 days postnatally shows a more typical trabeculated bladder with the 
characteristic tubular shape of the bladder base in prune belly syndrome. 
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3.4.2 Spina bifida 
Approximately 50% of children with myelomeningocele have detrusor-bladder sphincter 
dyssynergy, resulting in a functional bladder outlet obstruction and development of 
hydronephrosis (Anderson & Travers, 1993). These patients can develop the same 
complications as those with anatomical obstructions, including upper urinary tract 
dilatation, VUR, incomplete bladder emptying, recurrent urinary tract infections, and CKD 
(van Gool et al., 2001). 
4. Diagnosis of congenital obstructive nephropathy 
4.1 Prenatal ultrasound 
In developed countries, antenatal diagnosis of congenital urinary obstructions is often made 
in mid-gestation (at 18-20 weeks), when many pregnant women undergo a detailed prenatal 
ultrasound. Megacystis with or without oligohydramnios is the characteristic ultrasound 
finding of lower urinary tract obstruction, whereas hydronephrosis may signal upper or 
lower urinary tract obstruction. Hydronephrosis is the most commonly detected anomaly on 
prenatal ultrasound, found in as many as 4.5% of fetuses (Ismaili, et al., 2003). Prenatal 
hydronephrosis may result from non-obstructive processes such as primary VUR or 
physiologic dilatation as well as from obstruction. Differentiating obstruction from non-
obstructive causes of congenital hydronephrosis is critical because the prognosis and 
management vary significantly among these conditions. Factors for consideration in 
assessing fetal hydronephrosis include gestational age; gender; whether the finding is 
unilateral or bilateral; the degree of dilatation; the ultrasonic appearance of the renal 
parenchyma, including presence/absence of a kidney, echogenicity, evidence of cysts or 
dysplasia, cortical thickness, and corticomedullary differentiation; the presence, volume, 
and structure of the bladder; any evidence of dilatation elsewhere in the urinary tract; the 
presence of other abnormalities of the urogenital system (such as duplication) or outside the 
urinary tract; amniotic fluid volume; and the progression of all findings over serial 
evaluations (Pates & Dashe, 2006). Several diagnostic algorithms have been proposed for the 
evaluation of patients with prenatally detected hydronephrosis (de Kort et al., 2008; Ismaili 
et al., 2005; Karnak et al., 2009; Riccabona et al., 2008; Shokeir & Nijman, 2000; Yiee & 
Wilcox, 2008). 
4.2 Postnatal diagnosis 
In the neonate with a suspected urological obstruction, multiple modalities may be needed 
for full evaluation. Renal ultrasound and voiding cytourethrogram usually play important 
roles in postnatal assessment of these patients, and in some cases CT, MRI, diuretic 
renography, urodynamic studies, or cystoscopy may be useful.  
If not detected prenatally, congenital obstructive nephropathy may present in the 
neonate, infant, child, adolescent or adult with poor urine output, weak urine stream, 
abdominal distention, palpable abdominal or flank mass, pain, incontinence, urinary 
tract infection, hematuria, altered serum chemistries, or as an incidental finding on 
imaging studies. 
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4.3 Prospective diagnostic and prognostic biomarkers 
Many attempts have been made to identify useful diagnostic and prognostic biomarkers for 
congenital obstructive nephropathy. These include gestational age at diagnosis (Hutton et 
al., 1994); the volume of amniotic fluid (Oliveira et al., 2000; Sarhan et al., 2008); the presence 
of megacystis (Oliveira, et al., 2000); the appearance of the renal parenchyma on prenatal 
ultrasound (Morris et al., 2009; Robyr, et al., 2005; Sarhan, et al., 2008); fetal urinary sodium, 
calcium, 2-microglobulin, and other urinary solutes and proteins (Decramer et al., 2008; 
Morris et al., 2007). Additionally, pilot studies show that urine proteome analysis can 
identify urodynamically significant UPJ obstruction in infants with hydronephrosis with a 
sensitivity of 83% and a specificity of 92%, although the test had poor diagnostic accuracy in 
patients older than 1 year of age (Drube et al., 2010). Although several of these markers and 
tests show promise as diagnostic or prognostic tools, no consensus yet exists as to the best 
panel of biomarkers to assess congenital obstructive nephropathy. 
Prenatally, the volume of amniotic fluid as well as ultrasound appearance of the bladder, 
urethra, and kidneys are common discriminators of the plan of care. Analysis of fetal urine can 
provide additional information; fetal urinary sodium less than 100 mmol/L, chloride less than 
90 mmol/L, osmolality less than 210 mOsm/L, and low levels of urinary protein indicate good 
renal function (Shokeir & Nijman, 2000). Postnatally and in patients who present outside the 
neonatal period, management decisions are most frequently reliant on ultrasonography 
findings and other imaging modalities, coupled with serial measurements of serum creatinine. 
Serum creatinine is a relatively late marker of renal injury whose elevation often signals 
irreversible kidney damage (Nickavar et al., 2008; Sarhan et al., 2010). Nonetheless, nadir 
serum creatinine level is a useful and reliable prognostic indicator in patients with congenital 
obstructive nephropathy (Ansari et al., 2010; Bajpai et al., 2001; Warshaw et al., 1985). 
5. Clinical course, management, and outcomes 
The effects of fetal urinary tract obstruction on renal development, renal function, and 
urodynamics will be unique to each individual patient, and there may be significant clinical 
variability between patients thought to have similar obstructive lesions or processes. The 
clinical course is influenced by many factors; those intrinsic to each patient include the 
developmental stage at which the obstruction arises, the degree and duration of blockage, 
and its location. However, accurate tools to measure and determine the prognostic impact of 
these various factors in any individual case do not exist.  
5.1 Management of congenital upper urinary tract obstruction 
Regardless of the specific cause, unilateral upper urinary tract obstructive lesions rarely 
result in azotemia. Conservative management of these patients is often recommended, with 
surgery reserved for patients with clinical symptoms or declining renal function. However, 
over time up to 50% of patients with unilateral UPJ obstruction will meet these criteria and 
require surgical correction (Chertin et al., 2006). Additionally, some authors have raised 
concern about an increased long-term risk for hypertension as a result of ureteral 
obstruction, advocating for reconsideration of these conservative management approaches 
(Carlstrom, 2010). Relative to unilateral obstruction, bilateral upper tract obstruction or 
obstruction of a solitary functional kidney is far more ominous, and generally requires 
prompt surgical intervention and careful postsurgical management to minimize and 
monitor renal injury.  
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5.2 Natural history of lower urinary tract obstruction 
Obstruction of the bladder outlet or urethra affects urologic and renal functions at all points 
proximal to the lesion. Extrarenal effects may also occur, primarily in the lungs due to 
associated oligohydramnios. The profound changes that can result are outlined in Figure 6.  
 
Fig. 6. Cascade of physiological consequences associated with lower urinary tract obstruction. 
As many as 70% of boys with PUV develop advanced chronic or end-stage kidney disease 
(CKD Stage 3-5; Parkhouse et al., 1988; Reinberg et al., 1992; Roth et al., 2001; Sanna-Cherchi, 
et al., 2009). Those with ultrasound findings at or before 24 weeks’ gestation are significantly 
more likely to have a poor renal outcome than children with PUV detected later in 
pregnancy after a normal second trimester scan (Hutton, et al., 1994). Among patients with 
PUV who survive the perinatal period, bladder dysfunction and nadir serum creatinine 
greater than 1.0 mg/dl are independent risk factors for progression to end stage renal 
disease (Ansari, et al., 2010; DeFoor et al., 2008). Unilateral or bilateral VUR associated with 
PUV may also have a significant impact on kidney function (Heikkila et al., 2009).  
Long-term follow-up studies decades after treatment for PUV offer additional insight into 
the postnatal renal progression of this condition. Holmdahl and colleagues (2005) assessed 
Swedish men who were treated for PUV between 1956 and 1970. Over the 30 to 40 years 
between initial intervention and this follow-up assessment, the prevalence of ESRD in this 
population increased from 8% to 21%, and only 37% of the cohort had apparently normal 
renal function as adults (Holmdahl & Sillen, 2005). Kousidis et al. (2008) found that in a 
British cohort of patients diagnosed prenatally between 1984 and 1996, 28% died or 
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developed ESRD and 58% had normal renal function after a mean follow-up of 17.7 years. 
The authors of the latter study note that for the more severely affected patients, the 
functional outcome may be primarily determined by the severity of intrauterine obstruction 
and presence of renal dysplasia and not significantly altered by early diagnosis and 
treatment; however, for patients with more moderate disease, long-term prognosis may be 
improved by prenatal diagnosis and early interventions (Kousidis, et al., 2008). Other 
studies have not shown a statistically significant difference in outcomes between patients 
with renal dysplasia and those with normal-appearing kidneys (Nickavar, et al., 2008; 
Ylinen et al., 2004). 
5.3 Antenatal intervention 
Antenatal intervention for suspected fetal obstructive nephropathy has been attempted by 
vesicoamniotic shunting, vesicocentesis, fetal cystoscopy, or open fetal bladder surgery. The 
results are variable and these methods remain controversial. A 2003 meta-analysis of the 
available data suggested improved perinatal survival following prenatal bladder drainage, 
particularly in cases with poor predicted prognoses (Clark et al., 2003). However, these 
procedures carry a high risk for complications including shunt malfunction or migration, 
urinary ascites, hemorrhage, chorioamnionitis, iatrogenic gastroschisis, premature labor, or 
miscarriage (Carr & Kim, 2010; Elder et al., 1987). The Percutaneous shunting in Low 
Urinary Tract Obstruction (PLUTO) study, a multicenter, prospective, randomized trial, was 
designed to systematically evaluate the prenatal and perinatal outcomes and risk/benefit 
ratio of in utero intervention for urological obstruction versus conservative management, 
and is currently in the data analysis phase (Kilby et al., 2007; Morris & Kilby, 2009; 
University of Birmingham, 2011). 
5.4 Postnatal intervention 
In cases where renal function is affected or threatened, surgical relief of the obstruction or 
diversion of the urine path is necessary. Stents, catheters, or percutaneous drains may be 
useful to provide temporary drainage, but long-term management requires surgery. 
Discussion of the variety of surgical techniques and approaches that may be implemented in 
the management of congenital urinary obstructions is beyond the scope of this review.  
Although such surgical interventions can relieve some of the effects of congenital 
impairment of urine flow, many developmental and pathologic changes associated with this 
condition appear irreversible. Many patients with congenital obstructive nephropathy, 
including the majority of patients with PUV, do not have complete recovery of kidney 
function following postnatal intervention (Parkhouse, et al., 1988; Reinberg, et al., 1992; 
Roth, et al., 2001; Sanna-Cherchi, et al., 2009).  
5.5 Progressive chronic kidney disease in congenital obstructive nephropathy 
Given the frequency of chronic and progressive renal impairment, the importance of long-
term monitoring of all patients with congenital obstructive nephropathy cannot be 
overemphasized. Serial measurements of renal function, periodic urinalysis, blood pressure 
checks, and monitoring of growth should be performed for all patients with a history of 
congenital urinary obstruction. Renal impairment, if detected, should be fully evaluated and 
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managed, along with any complications of CKD such as hypertension, proteinuria, 
electrolyte abnormalities, metabolic acidosis, anemia, dyslipidemia, or renal bone disease. In 
young adult patients with congenital obstructive nephropathy and CKD, there is a strong 
correlation between proteinuria and rate of decline in renal function. The ItalKid Project found 
no benefit from angiotensin converting enzyme inhibitors (ACEi) in a population of patients 
with renal hypodysplasia, many of whom also had congenital obstructive nephropathy 
(Ardissino, 2007). However, a later study in young adults with congenital obstructive 
nephropathy or primary VUR with hypodysplasia indicated that ACEi can slow this decline in 
renal function, but impact renal outcome only when the estimated glomerular filtration rate is 
greater than 35 ml/min (Neild, 2009b). In patients with post-obstructive bladder dysfunction, 
an individualized voiding regimen designed to maintain bladder volume below a critical 
filling volume can stabilize deteriorating renal function (Hale et al., 2009).  
5.6 End-stage kidney disease due to congenital obstructive nephropathy 
For patients with congenital obstructive nephropathy who progress to ESRD, renal 
transplantation is generally a safe and effective therapy, with 5 year graft survival rates 
approximately 85% for living donor transplants and 72% for deceased donor grafts in 
patients with a primary diagnosis of obstructive nephropathy (NAPRTCS, 2009). 
Appropriate and effective management of any residual urinary tract dysfunction is critical 
to long-term outcomes following renal transplantation in patients with congenital 
obstructive nephropathy (Morita et al., 2009). 
6. Experimental models of congenital obstructive nephropathy 
The experimental analysis of urological obstructions dates back to antiquity. The physician 
Galen of Pergamon described ligature of both the ureter and the urethra in animals in the 
2nd century A.D. (Galen, 1914). In the 21st century, surgical introduction of a urologic 
obstruction is still an important research tool. Other animal models of congenital obstructive 
nephropathy have been created by non-surgical approaches, including genetic manipulation 
and chemical induction. This review focuses on animal models for investigating the 
consequences of obstruction on the subsequent maturation and function of the kidneys and 
urinary tract. For an analysis of how mouse models have contributed to understanding 
ureter and bladder organogenesis from the earliest stages of development, we recommend 
Dr. Mendelsohn’s excellent review (Mendelsohn, 2009). 
6.1 Surgical models 
6.1.1 Ureteral ligation/Unilateral ureteral obstruction 
The vast majority of data on the progression of renal injury following urinary tract 
obstruction has come from experiments involving surgical ligation of a ureter, a technique 
known as unilateral ureteral obstruction (UUO) (Bing et al., 2003; de Souza et al., 2004; 
Eroglu et al., 2004; Flynn et al., 2002; Hanai et al., 2002; Klahr & Morrissey, 2002; Stanton et 
al., 2003; Thiruchelvam et al., 2003). Several studies have examined partial or complete 
ureteral ligations in embryonic rabbits, opossums, and sheep (Becker & Baum, 2006; 
Kitajima et al., 2010; Steinhardt et al., 1994). In these models, animals develop 
hydroureteronephrosis in utero with variable degrees of renal dysplasia depending on the 
timing and severity of obstruction.  
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The majority of investigations using UUO have employed postnatal and adult rats, mice and 
pigs. In these species, nephrogenesis continues for a limited period after birth (Moritz & 
Wintour, 1999), so postnatal ligation in these animals may have some relevance to 
congenital ureteral obstructions. Even though postnatal models do not reproduce the fetal 
environment, the delay in renal maturation in rodents versus humans permits relative 
comparisons of the effects of obstruction on kidney development to be made. In addition, 
postnatal surgical models can isolate the effects of mechanical obstruction on the developing 
urinary tract from parallel renal maldevelopment, a concern that often confounds analysis of 
genetic models of congenital obstructive nephropathy. However, many obstructive lesions 
that lead to congenital obstructive nephropathy in humans arise earlier in the course of renal 
development, or exert their effects on the kidney more gradually, than the circumstances 
modeled by UUO. Therefore, the precise pathophysiological applicability of this model to 
congenital obstructive nephropathy remains to be determined.  
UUO in rodents has been shown to have profound and often irreversible effects on renal 
growth, maturation, and function in neonatal and adult animals. The progressive renal 
injury associated with UUO has been characterized as four overlapping stages: 1) interstitial 
inflammation, 2) tubular and myofibroblast proliferation, 3) tubular apoptosis, and 4) 
interstitial fibrosis (Bascands & Schanstra, 2005; Chevalier, 2006; Klahr & Morrissey, 2002). 
The renin-angiotensin and transforming growth factor  (TGF-) pathways appear to play 
critical roles in these changes (Bascands & Schanstra, 2005; Chevalier, 2006; Esteban et al., 
2004; Inazaki et al., 2004).  
6.1.2 Bladder outlet obstruction models 
Surgical introduction of a bladder outlet obstruction has been investigated in fetal sheep, 
immature guinea pigs, and young rats (Cendron et al., 1994; Kitagawa et al., 2001; Kitagawa 
et al., 2004; Mostwin et al., 1991; O'Connor et al., 1997). As in ureteral obstruction models, 
the effects of these urethral manipulations are also highly dependent on the timing and 
severity of the obstruction. Experimental urethral ligation resulted in a spectrum of findings 
ranging from minimal renal pathology to hydronephrosis, renal dysplasia, pulmonary 
hypoplasia and/or Potter’s sequence. Unfortunately, the data on surgical models of in utero 
bladder outlet obstruction are limited by small numbers of animals, and by the lack of 
complementary genetic studies since many of the large animal models are not easily 
amenable to genetic manipulation. 
6.2 Chemically-induced models  
The antineoplastic anthracycline antibiotic Adriamycin has well-known teratogenic effects, 
and has been used in pregnant rats to generate an animal model of congenital obstructive 
nephropathy (Kajbafzadeh et al., 2011; Thompson et al., 1978). At Adriamycin dosages 
above 1.5mg/kg/d, bladder hypoplasia or agenesis occurs in all offspring, but fetal viability 
is low. At decreased doses, Kajbafzadeh et al. (2011) observed a high frequency of 
hydronephrosis with coexisting bladder anomalies and minimal fetal lethality. The kidneys 
of these animals demonstrated cortical thinning and cystic dilatation of collecting ducts. 
However, Adriamycin-treated rats display multiple extrarenal anomalies consistent with the 
VATER/VACTERL association, including vertebral defects, anal atresia, tracheoesophageal 
www.intechopen.com
 
Novel Insights on Chronic Kidney Disease, Acute Kidney Injury and Polycystic Kidney Disease 
 
18
fistula with esophageal atresia, and radial limb dysplasia, which complicates application of 
this approach to modeling congenital obstructive nephropathy.  
6.3 Genetic models 
Although numerous genes have been postulated to play a role in the normal and abnormal 
development of the urinary tract, none have been shown to be directly responsible for the 
primary lesions associated with congenital obstructive nephropathy in humans. Even so, 
several mutational or transgenic rodent models of obstructive nephropathy have been 
described.  
6.3.1 Naturally-arising mutations associated with obstructive nephropathy 
Congenital progressive hydronephrosis, a hereditary condition in a mutant strain of 
C57BL/6J mice, results from a spontaneous point mutation in the aquaporin-2 gene. Affected 
mice produce excessive quantities of hypotonic urine, which is believed to exceed the 
capacity of the ureteral peristaltic machinery producing hydronephrosis, obstructive 
nephropathy, and death (McDill et al., 2006). Male C57BL/KsJ mice also have a high 
incidence of hydronephrosis, although the mechanism of this finding has not been identified 
(McDill, et al., 2006; Weide & Lacy, 1991). In both of these strains, hydronephrosis is not 
present at birth; therefore, the urological defect is hereditary, but not congenital. Genetic 
models that develop in utero obstruction include certain inbred lines of rats (Aoki et al., 2004; 
Fichtner et al., 1994; Miller et al., 2004) that develop unilateral UPJ obstruction. Some of 
these strains display minimal or no morphological change in the renal parenchyma, but one 
strain of Wistar rats has been shown to develop hydronephrosis, loss of renal parenchyma, 
tubular and ductal atrophy and dilation, and interstitial fibrosis (Seseke et al., 2000).  
6.3.2 Targeted models with complex phenotypes 
Mice with the targeted deletion of ADAMTS (a disintegrin and metalloproteinase with 
thrombospondin motifs), lysosomal membrane protein LIMP-2/LGP85, or calcineurin also 
develop urinary tract obstruction in the postnatal period (Chang et al., 2004; Gamp et al., 
2003; Yokoyama et al., 2002). Transgenic mice over-expressing human chorionic 
gonadotropin develop functional urethral obstruction that is not apparent until adulthood 
(Rulli et al., 2003). Mice deficient in the transcription factor Id2 (Aoki, et al., 2004; Fichtner, et 
al., 1994; Miller, et al., 2004) develop unilateral UPJ obstruction. Bilateral ureteral obstruction 
in utero has been reported in mice heterozygous for bone morphogenetic protein 4 (Miyazaki 
et al., 2000). However, each of these animal models exhibits complex urological phenotypes 
including renal hypoplasia, dysplasia, aplasia, ureteral tortuosity, or duplicated ureters, 
thereby confounding analysis due to the inextricability of the secondary effects of 
obstruction from primary renal maldevelopment.  
Developmental urinary tract anomalies including hydronephrosis also arise from knockout 
of the uroplakin II or III genes and conditional knockout of homeobox gene Lim1 in the 
nephric duct epithelium (Hu et al., 2000; Kong et al., 2004; Pedersen et al., 2005). However, 
VUR is also a prominent feature in these CAKUT models, and it is not clear whether there is 
a true or a functional obstruction, nor what the relative contributions of reflux and 
obstruction to the renal phenotype are.  
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Mice lacking either of the two angiotensin receptors likewise develop abnormal renal 
phenotypes. The Agtr2 knockout has incomplete penetrance, with approximately 2-20% of 
mutant mice demonstrating a wide spectrum of renal and urological anomalies including 
UPJ stenosis or megaureter as well as multicystic dysplastic kidney, hypoplastic kidney, 
VUR, or duplicated ureter (Nishimura, et al., 1999). Deficiency of Agtr1 produces a renal 
phenotype with some features similar to that seen in complete UUO, including papillary 
atrophy, medullary thinning, calyceal enlargement, tubulointerstitial apoptosis, macrophage 
infiltration, and fibrosis. The Agtr1 mutant also demonstrates hypertrophy of the renal 
vasculature, a feature not seen in UUO models. There is some evidence supporting a role for 
Agtr1 in promoting growth and contractility of smooth muscle cells (Miyazaki & Ichikawa, 
2001), but the relative contributions of primary effects of the mutation on renal development 
and secondary consequences of a possible functional obstruction in these mice remain 
unclear. Agtr1 knockout mice also display significant extrarenal abnormalities, including 
poor weight gain, marked hypotension, and increased frequency of ventral septal defects 
(Tsuchida et al., 1998).  
6.3.3 Megabladder mouse 
Our laboratory has identified a unique transgenic mouse model of congenital obstructive 
nephropathy designated the megabladder (mgb) mouse (Ingraham et al., 2010; Singh et al., 
2007). As shown in Figure 7, these mice develop a nonfunctional, over-distended bladder 
due to a bladder-specific defect in smooth muscle differentiation. This leads to a functional 
lower urinary tract obstruction, antenatal hydronephrosis, and signs of renal failure evident 
shortly after birth. Male mgb homozygotes develop early renal insufficiency and rarely 
survive beyond 4-6 weeks, whereas females may live a year or longer.  
Megabladder mice closely mirror the pathophysiology associated with a lower urinary tract 
obstruction in several key respects (Ingraham, et al., 2010; Singh, et al., 2007). Mgb-/- mice 
develop a functional obstruction of the lower urinary tract that leads to hydroureteronephrosis 
during embryogenesis. Mgb-/- mice are born with histopathological evidence of renal injury, 
indicating that their kidneys possess preexisting pathological changes resulting from in utero 
obstruction. The obstruction and its renal consequences develop within the uterine and fetal 
environment, in contrast to the postnatal timing of obstruction in UUO and many genetic 
models of obstructive nephropathy. Mgb-/- mice preferentially develop right-sided 
hydronephrosis reminiscent of the “pop-off” mechanism theorized in children with PUV and 
secondary unilateral VUR (Greenfield, et al., 1983). Mgb-/- mice also exhibit a variable clinical 
course, in much the same way that children with seemingly identical obstructive lesions may 
have very different clinical outcomes. Male mgb-/- mice can be rescued from the complications 
of renal failure and early demise by cutaneous vesicostomy, but of the vesicostomized animals 
that survive the perioperative period, approximately 40% die within the first two weeks 
despite a patent stoma and no apparent surgical complications. This result is reminiscent of the 
fact that 27% to 70% of children with PUV will have progressive CKD despite surgery (Ansari, 
et al., 2010; Kousidis, et al., 2008; Parkhouse, et al., 1988; Roth, et al., 2001; Sanna-Cherchi, et al., 
2009). Finally, mgb-/- mice possess no extrarenal features to complicate their utilization as a 
functional model of congenital obstructive nephropathy. Taken together, these observations 
suggest that mgb-/- mice represent an excellent experimental model for the study of the 
pathophysiological events associated with congenital obstructive nephropathy involving the 
lower urinary tract.  
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In the kidneys of mgb-/- mice, fibrotic changes are observed in a distinctive pattern. 
Increased interstitial collagen deposition is first apparent in the renal parenchyma 
immediately subadjacent to the urothelium of the renal capsule, followed by the outer cortex 
near the renal capsule. In severe cases, fibrosis ultimately extends throughout the renal 
parenchyma. Altered patterns of -smooth muscle isoactin (-SMA), E-cadherin, TGF-1 
and connective tissue growth factor expression are also observed in mgb-/- kidneys, 
supporting a role for these pathways in the development of fibrosis associated with 
congenital obstructive nephropathy (Ingraham, et al., 2010). Severely affected mgb-/- kidneys 
also display several dysplastic features including alteration in the developmental 
distribution of WT1 and PAX2. These observations are consistent with Edith Potter’s classic 
work suggesting that the renal pathology associated with CAKUT includes varying degrees 
of renal hypodysplasia (Potter, 1972). In contrast to the well-characterized UUO model of 
upper urinary tract obstruction, inflammation does not appear to play a prominent or early 
role in the pathogenesis of renal injury in the megabladder model.  
 
Fig. 7. Megabladder (mgb) mouse. A. Two mgb-/- mice, prior to (right) and immediately after 
(left) cutaneous vesicostomy. The mouse on the right demonstrates a massively distended 
abdomen secondary to the megabladder, whereas the mouse on the left demonstrates the 
flat belly attained with decompression of the bladder. B. Upon dissection and with the 
megabladder (MGB) reflected caudally, hydroureteronephrosis involving both kidneys (RK 
and LK) is apparent. C. Trichrome staining demonstrates a band of fibrosis (white arrows) 
underlying the urothelium in a mildly affected mgb-/- mouse. D. In a more severely affected 
kidney from a mgb-/- mouse, interstitial fibrosis (blue staining) extends throughout the renal 
medulla, and in a stripe along the outer cortex (yellow arrows) adjacent to the renal capsule. 
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7. Conclusion 
Morbidity and mortality remain very high for patients with congenital obstructive 
nephropathy, with few effective therapeutic options. Clearly, additional research is needed 
to illuminate the cellular and molecular changes that characterize congenital obstructive 
nephropathy, with particular emphasis on developing reliable biomarkers and new 
therapeutic approaches to reduce the impact of this devastating disease. Experimental 
animal models of obstructive nephropathy have provided valuable information regarding 
renal pathogenesis and function following surgical occlusion or genetic manipulation. The 
continued development of new animal models of congenital obstructive nephropathy, like 
the mgb mouse, will provide increasing opportunities to identify and manipulate the key 
molecular pathways associated with the development of chronic renal failure, while at the 
same time providing an experimental platform for biomarker development and the 
assessment of novel therapeutic strategies. 
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